The clinical evaluation of fever is a common yet challenging aspect of medical practice. This article aims to provide a comprehensive guide to effectively assess and manage fever in the clinical setting.
Fever represents a physiological response to infection, inflammation, or other internal disorders. It is typically identified when the body temperature exceeds 38.0°C (100.4°F). However, the clinical significance of fever extends beyond a mere symptom. It can serve as a valuable diagnostic clue, guiding the clinician towards the underlying cause.
The evaluation of fever should be systematic and patient-centered. The history should focus on the onset, duration, pattern, and associated symptoms. The physical examination should be thorough, emphasizing signs that may suggest specific etiologies. Laboratory investigations, including complete blood count, C-reactive protein, and cultures, may provide additional information. Imaging studies can also be useful in certain scenarios.
Management of fever depends on the underlying cause. In infectious causes, antimicrobial therapy is the mainstay of treatment. Inflammatory or autoimmune disorders may require immunosuppressive agents. Symptomatic management of fever with antipyretics should be considered, especially in patients with discomfort or significant comorbidities.
In certain populations, such as the elderly or immunocompromised, fever may be absent or subtle despite serious underlying conditions. Hence, a high index of suspicion is necessary. Similarly, fever of unknown origin (FUO) presents a diagnostic challenge, necessitating a broad differential and extensive workup.
Fever is a common clinical presentation with a broad differential. A comprehensive, systematic approach to evaluation can help clinicians identify the underlying cause and initiate appropriate management. By understanding the nuances of fever assessment, clinicians can enhance patient care and outcomes.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation